212 related articles for article (PubMed ID: 33570635)
1. Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors.
Shanmugam V; Craig JW; Hilton LK; Nguyen MH; Rushton CK; Fahimdanesh K; Lovitch S; Ferland B; Scott DW; Aster JC
Blood Adv; 2021 Jan; 5(1):71-83. PubMed ID: 33570635
[TBL] [Abstract][Full Text] [Related]
2. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
Lee SY; Kumano K; Nakazaki K; Sanada M; Matsumoto A; Yamamoto G; Nannya Y; Suzuki R; Ota S; Ota Y; Izutsu K; Sakata-Yanagimoto M; Hangaishi A; Yagita H; Fukayama M; Seto M; Kurokawa M; Ogawa S; Chiba S
Cancer Sci; 2009 May; 100(5):920-6. PubMed ID: 19445024
[TBL] [Abstract][Full Text] [Related]
4. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
[TBL] [Abstract][Full Text] [Related]
5. Role of Notch2 pathway in mature B cell malignancies.
Mesini N; Fiorcari S; Atene CG; Maffei R; Potenza L; Luppi M; Marasca R
Front Oncol; 2022; 12():1073672. PubMed ID: 36686759
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.
Kiel MJ; Velusamy T; Betz BL; Zhao L; Weigelin HG; Chiang MY; Huebner-Chan DR; Bailey NG; Yang DT; Bhagat G; Miranda RN; Bahler DW; Medeiros LJ; Lim MS; Elenitoba-Johnson KS
J Exp Med; 2012 Aug; 209(9):1553-65. PubMed ID: 22891276
[TBL] [Abstract][Full Text] [Related]
7. CAD204520 Targets
Pagliaro L; Cerretani E; Vento F; Montanaro A; Moron Dalla Tor L; Simoncini E; Giaimo M; Gherli A; Zamponi R; Tartaglione I; Lorusso B; Scita M; Russo F; Sammarelli G; Todaro G; Silini EM; Rigolin GM; Quaini F; Cuneo A; Roti G
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255842
[No Abstract] [Full Text] [Related]
8. NOTCH signaling in the pathogenesis of splenic marginal zone lymphoma-opportunities for therapy.
Alderuccio JP; Lossos IS
Leuk Lymphoma; 2022 Feb; 63(2):279-290. PubMed ID: 34586000
[TBL] [Abstract][Full Text] [Related]
9. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
10. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
[TBL] [Abstract][Full Text] [Related]
11. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.
Karube K; Martínez D; Royo C; Navarro A; Pinyol M; Cazorla M; Castillo P; Valera A; Carrió A; Costa D; Colomer D; Rosenwald A; Ott G; Esteban D; Giné E; López-Guillermo A; Campo E
J Pathol; 2014 Nov; 234(3):423-30. PubMed ID: 25141821
[TBL] [Abstract][Full Text] [Related]
12. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
13. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
14. Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL.
De Falco F; Sabatini R; Del Papa B; Falzetti F; Di Ianni M; Sportoletti P; Baldoni S; Screpanti I; Marconi P; Rosati E
Oncotarget; 2015 Jun; 6(18):16559-72. PubMed ID: 26041884
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.
Trøen G; Nygaard V; Jenssen TK; Ikonomou IM; Tierens A; Matutes E; Gruszka-Westwood A; Catovsky D; Myklebost O; Lauritzsen G; Hovig E; Delabie J
J Mol Diagn; 2004 Nov; 6(4):297-307. PubMed ID: 15507668
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
17. The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.
Zhang X; Shi Y; Weng Y; Lai Q; Luo T; Zhao J; Ren G; Li W; Pan H; Ke Y; Zhang W; He Q; Wang Q; Zhou R
PLoS One; 2014; 9(10):e108747. PubMed ID: 25314575
[TBL] [Abstract][Full Text] [Related]
18. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
[TBL] [Abstract][Full Text] [Related]
19. Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.
Mangolini M; Maiques-Diaz A; Charalampopoulou S; Gerhard-Hartmann E; Bloehdorn J; Moore A; Giachetti G; Lu J; Roamio Franklin VN; Chilamakuri CSR; Moutsopoulos I; Rosenwald A; Stilgenbauer S; Zenz T; Mohorianu I; D'Santos C; Deaglio S; Hodson DJ; Martin-Subero JI; Ringshausen I
Nat Commun; 2022 Oct; 13(1):6220. PubMed ID: 36266281
[TBL] [Abstract][Full Text] [Related]
20. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
